Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Mammography: A Billion Without Benefit?

Can you spend a billion on breast cancer screenings without benefit? Researchers at Yale School of Medicine believe the answer is yes

RBMA Educational Scholarships Now Available

For the third consecutive year, the association has teamed with vRad to offer scholarships to help cover the cost of attending its seminars and annual meeting

Oslo Screening Trial Finds Higher Cancer Detection With Tomosynthesis

Study concludes that 3D mammography combined with 2D breast exam finds significantly more cancers than a 2D breast exam alone

Including CT Colongraphy into HEDIS Can Increase Colorectal Cancer Screening Compliance

Colorectal cancer (CRC) screening rates increased when CT colonography (CTC) was included as a HEDIS-compliant CRC test, according to a JACR study

Global Breast Imaging Market Will Grow to $5 Billion by 2017, According to New Report

The global breast imaging market will grow to approximately $5 billion by 2017 at a CAGR of 15.37% from 2012, according to marketandmarkets.com

Chinese Imaging Provider Acquires Ownership Interest in MD Anderson Proton Therapy Center

Concord Medical Services, based in China, has closed the acquisition of 19.98% of indirect ownership of the University of Texas MD Anderson Proton Therapy Center

iCAD Digital CAD Approved for Use with Philips Digital Mammography System

The FDA has approved iCAD’s PowerLook Advanced Mammography Platform (AMP), with Digital CAD for Philips’ MicroDose Full-Field Digital Mammography System

ACS Comes Out in Favor of CT Lung Cancer Screening for Heavy Smokers

The move by the influential American Cancer Society (ACS) will push more payors to cover the test and adds pressure to develop national guidelines and practice standards